Accolade Financials
| ACCDDelisted Stock | USD 7.02 0.00 0.00% |
Accolade, |
Understanding current and past Accolade, Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Accolade,'s financial statements are interrelated, with each one affecting the others. For example, an increase in Accolade,'s assets may result in an increase in income on the income statement.
Please note, the presentation of Accolade,'s financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Accolade,'s management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Accolade,'s management manipulating its earnings.
Accolade, Stock Summary
Accolade, competes with Claritev. Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania. Accolade operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 2350 people.| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US00437E1029 |
| Business Address | 1201 Third Avenue, |
| Sector | Health Care Technology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.accolade.com |
| Phone | 206 926 8100 |
| Currency | USD - US Dollar |
Accolade, Key Financial Ratios
| Return On Equity | -0.48 | |||
| Return On Asset | -0.075 | |||
| Target Price | 7.03 | |||
| Beta | 2.1 |
Accolade, Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Accolade,'s current stock value. Our valuation model uses many indicators to compare Accolade, value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Accolade, competition to find correlations between indicators driving Accolade,'s intrinsic value. More Info.Accolade is rated fifth in return on equity category among its peers. It is rated fourth in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Accolade, by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Accolade, Financials
What exactly are Accolade, Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Accolade,'s income statement, its balance sheet, and the statement of cash flows. Potential Accolade, investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Accolade, investors may use each financial statement separately, they are all related. The changes in Accolade,'s assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Accolade,'s income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Accolade, February 19, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Accolade, help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Accolade. We use our internally-developed statistical techniques to arrive at the intrinsic value of Accolade based on widely used predictive technical indicators. In general, we focus on analyzing Accolade, Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Accolade,'s daily price indicators and compare them against related drivers.
| Downside Deviation | 1.07 | |||
| Information Ratio | 0.1198 | |||
| Maximum Drawdown | 105.21 | |||
| Value At Risk | (0.29) | |||
| Potential Upside | 0.5848 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Accolade, Stock
If you are still planning to invest in Accolade, check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Accolade,'s history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |